157 related articles for article (PubMed ID: 16255750)
1. Effects of mobile telephones on the function of implantable cardioverter defibrillators.
Tandogan I; Ozin B; Bozbas H; Turhan S; Ozdemir R; Yetkin E; Topal E
Ann Noninvasive Electrocardiol; 2005 Oct; 10(4):409-13. PubMed ID: 16255750
[TBL] [Abstract][Full Text] [Related]
2. [Do mobile telephones have adverse effects on the functions of implantable cardioverter defibrillators?].
Tandoğan I; Ileri M; Yetkin E; Temizhan A; Aras D; Sezgin AT; Biyikoğlu F; Saşmaz A
Anadolu Kardiyol Derg; 2002 Mar; 2(1):45-8, AXVII. PubMed ID: 12101794
[TBL] [Abstract][Full Text] [Related]
3. [The absence of interference between GSM mobile telephones and implantable defibrillators: an in-vivo study. Groupe Systèmes Mobiles].
Sanmartín M; Fernández Lozano I; Márquez J; Antorrena I; Bautista A; Silva L; Ortigosa J; de Artaza M
Rev Esp Cardiol; 1997 Oct; 50(10):715-9. PubMed ID: 9417561
[TBL] [Abstract][Full Text] [Related]
4. Implantable cardioverter defibrillators and cellular telephones: is there any interference?
Occhetta E; Plebani L; Bortnik M; Sacchetti G; Trevi G
Pacing Clin Electrophysiol; 1999 Jul; 22(7):983-9. PubMed ID: 10456625
[TBL] [Abstract][Full Text] [Related]
5. Heart failure and the risk of shocks in patients with implantable cardioverter defibrillators: results from the Triggers Of Ventricular Arrhythmias (TOVA) study.
Whang W; Mittleman MA; Rich DQ; Wang PJ; Ruskin JN; Tofler GH; Muller JE; Albert CM;
Circulation; 2004 Mar; 109(11):1386-91. PubMed ID: 14993132
[TBL] [Abstract][Full Text] [Related]
6. Implantable transvenous cardioverter-defibrillators.
Bardy GH; Hofer B; Johnson G; Kudenchuk PJ; Poole JE; Dolack GL; Gleva M; Mitchell R; Kelso D
Circulation; 1993 Apr; 87(4):1152-68. PubMed ID: 8462144
[TBL] [Abstract][Full Text] [Related]
7. Electromagnetic interference of digital and analog cellular telephones with implantable cardioverter defibrillators: in vitro and in vivo studies.
Barbaro V; Bartolini P; Bellocci F; Caruso F; Donato A; Gabrielli D; Militello C; Montenero AS; Zecchi P
Pacing Clin Electrophysiol; 1999 Apr; 22(4 Pt 1):626-34. PubMed ID: 10234716
[TBL] [Abstract][Full Text] [Related]
8. Utility of postoperative testing of implantable cardioverter-defibrillators.
Sauer WH; Lowery CM; Bargas RL; Schuller JL; Stees CS; Aleong RG; Varosy PD
Pacing Clin Electrophysiol; 2011 Feb; 34(2):186-92. PubMed ID: 21039640
[TBL] [Abstract][Full Text] [Related]
9. Factors influencing the use of subcutaneous or transvenous implantable cardioverter-defibrillators: results of the European Heart Rhythm Association prospective survey.
Boveda S; Lenarczyk R; Fumagalli S; Tilz R; Goscinska-Bis K; Kempa M; Defaye P; Marquié C; Capucci A; Ueberham L; Dagres N
Europace; 2018 May; 20(5):887-892. PubMed ID: 29432525
[TBL] [Abstract][Full Text] [Related]
10. Sudden death in implantable cardioverter-defibrillator recipients: clinical context, arrhythmic events and device responses.
Pires LA; Lehmann MH; Steinman RT; Baga JJ; Schuger CD
J Am Coll Cardiol; 1999 Jan; 33(1):24-32. PubMed ID: 9935004
[TBL] [Abstract][Full Text] [Related]
11. Ranolazine in High-Risk Patients With Implanted Cardioverter-Defibrillators: The RAID Trial.
Zareba W; Daubert JP; Beck CA; Huang DT; Alexis JD; Brown MW; Pyykkonen K; McNitt S; Oakes D; Feng C; Aktas MK; Ayala-Parades F; Baranchuk A; Dubuc M; Haigney M; Mazur A; McPherson CA; Mitchell LB; Natale A; Piccini JP; Raitt M; Rashtian MY; Schuger C; Winters S; Worley SJ; Ziv O; Moss AJ;
J Am Coll Cardiol; 2018 Aug; 72(6):636-645. PubMed ID: 30071993
[TBL] [Abstract][Full Text] [Related]
12. Interference of electrical dental equipment with implantable cardioverter-defibrillators.
Brand HS; Entjes ML; Nieuw Amerongen AV; van der Hoeff EV; Schrama TA
Br Dent J; 2007 Nov; 203(10):577-9. PubMed ID: 18037843
[TBL] [Abstract][Full Text] [Related]
13. Lack of interference of electromagnetic navigation bronchoscopy to implanted cardioverter-defibrillator: in-vivo study.
Magnani A; Balbo P; Facchini E; Occhetta E; Marino P
Europace; 2014 Dec; 16(12):1767-71. PubMed ID: 25082949
[TBL] [Abstract][Full Text] [Related]
14. Effect of digital cellular phones on tachyarrhythmia analysis of automated external defibrillators.
Kanz KG; Kay MV; Biberthaler P; Russ W; Lackner CK; Mutschler W
Eur J Emerg Med; 2004 Apr; 11(2):75-80. PubMed ID: 15028895
[TBL] [Abstract][Full Text] [Related]
15. Effect of substance abuse on defibrillation threshold in patients with implantable cardioverter-defibrillator.
Perrine SA; Nayak R; Bharadwaj AS; McKelvey G; Mohamad T; Jacob S
Pacing Clin Electrophysiol; 2011 Feb; 34(2):193-9. PubMed ID: 20946279
[TBL] [Abstract][Full Text] [Related]
16. In-vivo testing of digital cellular telephones in patients with implantable cardioverter-defibrillators.
Chiladakis JA; Davlouros P; Agelopoulos G; Manolis AS
Eur Heart J; 2001 Aug; 22(15):1337-42. PubMed ID: 11465966
[TBL] [Abstract][Full Text] [Related]
17. Electrocautery-induced ventricular tachycardia and fibrillation during device implantation and explantation.
Lo R; Mitrache A; Quan W; Cohen TJ
J Invasive Cardiol; 2007 Jan; 19(1):12-5. PubMed ID: 17297178
[TBL] [Abstract][Full Text] [Related]
18. Multicenter experience with a pectoral unipolar implantable cardioverter-defibrillator. Active Can Investigators.
Bardy GH; Yee R; Jung W
J Am Coll Cardiol; 1996 Aug; 28(2):400-10. PubMed ID: 8800117
[TBL] [Abstract][Full Text] [Related]
19. Low risk of electromagnetic interference between smartphones and contemporary implantable cardioverter defibrillators.
Burri H; Mondouagne Engkolo LP; Dayal N; Etemadi A; Makhlouf AM; Stettler C; Trentaz F
Europace; 2016 May; 18(5):726-31. PubMed ID: 26857191
[TBL] [Abstract][Full Text] [Related]
20. Driving and implantable cardioverter-defibrillators a clearer view.
Grubb BP
J Am Coll Cardiol; 2007 Dec; 50(23):2241-2. PubMed ID: 18061072
[No Abstract] [Full Text] [Related]
[Next] [New Search]
